A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease
It helps stimulate your own insulin production, slows down digestion and may reduce appetite by lowering glucagon levels
Crossing strategies are: (1) bypassing intranasal route, (2) lipid modifications (Dihexa), (3) active transporters (insulin, transferrin), (4) vehicles like nanoparticles or exosomes
The majority of these are cardio-protective, including lowering systolic and diastolic blood pressure [5, 6] and attenuating hypotension induced by intraduodenal glucose infusion [7], lowering plasma cholesterol level [5, 8] and ischemiareperfusion injury [9], and delaying the progression of atherosclerotic disease [9]
Some New Delhi and Mumbai-based chemists also bring treatments from countries like United Arab Emirates or Egypt, and sell bulk packs for cash, according to an investigation published in March by India Today